The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia, the FDA announced Thursday.The ...

PureTech Health has obtained approval from the US Food and Drug Administration (FDA) for KarXT to treat schizophrenia in ...

Cobenfy is the first schizophrenia drug in decades to treat the mental health condition in a new way, with potentially fewer ...

Recent research is painting a clearer picture of the link between the use of clozapine for schizophrenia and respiratory ...

Bristol-Myers Squibb Company (BMY) shares rose 1.6% after the FDA approved its new drug for schizophrenia. Shares of Cassava Sciences (SAVA) plunged 10.6% after the company reached a $40 million ...

The US Food and Drug Administration (FDA) has approved xanomeline and trospium chloride capsules (Cobenfy) for the treatment of schizophrenia in adults. The drug is the first antipsychotic treatment ...

New drug for schizophrenics has experts excited Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in decades. "This drug takes ...

Alembic Pharma gets US FDA approval for paliperidone ER tablets: Our Bureau, Bengaluru Monday, September 30, 2024, 11:30 Hrs [IST] Alembic Pharmaceuticals has received final appro ...

Cognitive decline may increase an older person's risk for a fall, while the trauma that follows a fall may also speed up ...

The FDA approved a new drug for schizophrenia. Discrimination is stressing Chinese Americans and damaging their mental health.

The U.S.Centers for Disease Control and Prevention on Monday said it was in conversation with Rwandan health officials amid ...

Bristol Myers Squibb climbed 1.5% after the FDA approved its schizophrenia drug. This marks the first new treatment option ...